NEW YORK, Feb. 27, 2017 /PRNewswire/ -- Alexandria Real
Estate Equities, Inc. (NYSE: ARE), an urban office REIT uniquely focused on collaborative life science and technology campuses in
AAA innovation cluster locations, today announced that Alexandria LaunchLabs ® has selected a leading-edge group of life science startups as its first
member companies. Alexandria LaunchLabs is New York City's first-in-class, highly affordable,
full-service wet laboratory and office co-working space, which provides unique access to Alexandria's early-stage investment capital. Alexandria LaunchLabs' member companies will also have full
access to Alexandria's world-class network and a highly amenitized campus, including a
state-of-the-art conference, event and meeting space; two farm-to-table restaurants and a fully equipped fitness center.
In addition, Alexandria Venture Investments, its strategic venture capital arm and one of New York
City's largest providers of early-stage life science venture capital, made its first New York
City-based investment of 2017, leading the Series A financing for Applied Therapeutics Inc. Applied Therapeutics, a
biotech company with technology licensed from Columbia University, is focused on developing
transformative drugs in areas of high unmet medical need.
Alexandria LaunchLabs Selects First Member Companies for Unique Startup Platform
Located at the Alexandria Center ® for Life Science, NYC's first and only premier life science campus,
Alexandria LaunchLabs has accepted its first group of member companies and continues to review new applications. The Alexandria team evaluates each prospective member company based on the following criteria: differentiated
technology, foundational intellectual property, compelling business strategy, strong management team and sound financing plan.
The high level of interest from entrepreneurs and life science startups eager to join Alexandria LaunchLabs reflects the strong
demand for Alexandria's full-service member offerings. As a critical component of Alexandria
LaunchLabs, Alexandria will address a key unmet need to provide seed-stage investment capital to
select member companies as well as other promising startups through its seed-funding mechanism.
"Alexandria has dedicated significant human and strategic risk capital to building the NYC
life science cluster," said Jenna Foger, senior principal of science and technology at Alexandria
Real Estate Equities, Inc. and Alexandria Venture Investments. "Now, extending this commitment through Alexandria LaunchLabs, we
will provide all of the resources necessary to catalyze the next generation of homegrown life science companies, which are
critical to the evolution and success of the city's life science community."
Alexandria LaunchLabs will open its doors to member companies this spring, with a launch event in connection with the NYC Life
Science Innovation Showcase. The showcase will be hosted at the Alexandria Center for Life Science on June
13, 2017, in partnership with the New York Academic Consortium.
Alexandria Venture Investments' First NYC-Based Investment of 2017 and Deep Commitment to Fostering Life Science Innovation
in NYC
Alexandria Venture Investments has been instrumental in advancing the early-stage company landscape in NYC. As part of its
continued support of life science companies in NYC, Alexandria Venture Investments made its first NYC-based investment of 2017 in
Applied Therapeutics, a biotech company translating proprietary discoveries from Dr. Donald
Landry's laboratory at Columbia University into new treatments for metabolic and
cardiovascular diseases.
"We are thrilled to receive Alexandria Venture Investments' financial and strategic support as we develop new therapies to
address key unmet medical needs in metabolic and cardiovascular diseases," said Shoshana
Shendelman, Ph.D., founder, chief executive officer and chairman of the board of Applied Therapeutics. "Having recruited
our core intellectual property and experienced management talent from the local community, we share Alexandria's commitment to retaining and cultivating homegrown companies here in NYC."
Dating back to 2002, Alexandria Venture Investments was an original investor in Intra-Cellular Therapies, Inc., one of NYC's
first venture-backed companies and now a publicly traded, clinical-stage company based on novel discoveries from Nobel laureate
Dr. Paul Greengard's laboratory at The Rockefeller University. Since
2014, Alexandria Venture Investments has invested in excess of $25 million in NYC-based early-stage
life science companies, including Accelerator Corporation, Bridge Medicines, EpiBone, Kallyope Inc., Lodo Therapeutics
Corporation, Lycera Corp., MeiraGTx, Petra Pharma Corporation, Rgenix, Inc. and TARA Biosystems, Inc.
Alexandria has been a leader in transforming NYC into a thriving life science cluster by
bringing together NYC's world-renowned academic and medical institutions, top scientific and managerial talent and sophisticated
capital. Alexandria's long-standing commitment to the NYC life science community, its proven
investment track record, its underwriting expertise and its world-class network uniquely position the company to accelerate the
life science cluster's next phase of significant growth.
About Alexandria LaunchLabs® at the Alexandria Center® for Life Science – New York City
Alexandria LaunchLabs is New York City's unique, full-service startup platform designed to
satisfy a key unmet need for affordable space for early-stage life science companies in New York
City. Located at the Alexandria Center for Life Science – New York City, Alexandria
LaunchLabs provides move-in-ready laboratory/office space, first-class support resources, shared equipment and services, creative
amenities and access to startup capital – all of which are critical for dramatically accelerating the growth of early-stage
companies in New York City. To submit an application, please visit apply.launchlabsnyc.com.
MEMBERSHIP INCLUDES:
- Affordable, shared wet laboratory and office spaces, for as low as $1,995 per month
- Full-service operations and management
- Shared laboratory equipment, conference, huddle and break rooms
- Comprehensive IT/AV package
- Open lounge and event spaces
- Café and breakout areas
- Access to Alexandria Center campus amenities and services
- Strategic programming and mentorship
- Connectivity with Alexandria's robust life science network
- Access to seed capital
About Alexandria Venture Investments
Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities, Inc. (NYSE: ARE).
Since 1996, Alexandria Venture Investments has provided strategic investment capital to the life science and technology
industries. Alexandria Venture Investments focuses on novel, breakthrough discoveries in biopharmaceuticals, diagnostics,
research tools, agtech, digital health and technology. Based on its experience and in-depth understanding of the life science and
technology industries, its long-term relationships with leading investors and its world-class international scientific advisory
network, Alexandria Venture Investments is uniquely positioned to fund early- and growth-stage companies.
About Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc. (NYSE: ARE) is an urban office REIT uniquely focused on collaborative life science and
technology campuses in AAA innovation cluster locations, with a total market capitalization of $14.2
billion and an asset base in North America of 25.2 million square feet as of December 31, 2016. The asset base in North America includes 19.9 million RSF
of operating properties and development and redevelopment of new Class A properties (under construction or pre-construction) and
5.3 million square feet of future ground-up development projects. Founded in 1994, Alexandria
pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York
City, San Diego, Seattle, Maryland and Research Triangle Park. Alexandria has a longstanding and
proven track record of developing Class A properties clustered in urban life science and technology campuses that provide its
innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and
retain world-class talent and inspire productivity, efficiency, creativity and success. For more information, please visit
www.are.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alexandria-launchlabs-nycs-premier-life-science-startup-platform-selects-its-first-member-companies-300413592.html
SOURCE Alexandria Real Estate Equities, Inc.